Subscribe to
our newsletters

Subscribe to our newsletters!

Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.

Search in Nordic Life Science Insight

-
June 23, 2021
Turku Business Region

Brinter pushing the frontier of medical science with 3D bioprinting

Brinter pushing the frontier of medical science with 3D bioprinting

Brinter aims to revolutionise the manufacturing of personalised drugs and bioprinted organ transplants with newly raised capital. The Turku-based company received million-dollar financing from private equity investor Innovestor.

The Turku-based bioprinting start-up received €1.2M in funding from the venture capital investor Innovestor. The company will use the capital to further expand its operations internationally in Europe and the US. Brinter boldly aims to put bioprinting within reach of every pharmaceutical company, hospital, university, and research center.

""
CEO Tomi Kalpio says that bioprinting means more personalized care.

Medical research facilities and universities often still rely on traditional methods of discovery in the research of new drugs, understanding diseases, and finding medical ways to help people.

“Bioprinting has the capability to rapidly unlock the opportunities behind long-running but unrealized science and research. This will improve the quality of life for patients, thanks to a more personalized care and bioprinted “spare parts” that can save lives, ” explains Brinter CEO Tomi Kalpio.

ProHealth Growth supporting growth

Brinter launched its first product in 2019, and is currently active in over 10 countries, including Germany and the UK. In 2020, Brinter was selected as one of the top eight 3D bioprinting companies in the world.

“Brinter is an exemplary success story of a promising start-up, and we are thrilled that the company is participating in the ProHealth Growth Programme, which provides a boost and support to Brinter’s successful business development”, tells Hanna Halme, Growth Advisor at Turku Science Park Ltd.

The Finnish national ProHealth Growth Programme is coordinated by Turku Science Park Ltd and offers participating companies webinars and one-on-one coaching, making use of programme’s strong network of individuals and companies with deep experience and wide-ranging Life Science competencies in fields like development, patenting, commercialization, legal, regulatory, quality and financing. More information about the programme here.

Last updated:
June 23, 2021

Turku Business Region

Turku Business Region gathers together the Turku region businesses, universities, organisations and municipalities. The 22,000 companies, six universities, and an extensive co-operation network of different players in the region speed up the generation of new products and services as well as growth of business operations and local well-being.

Click here to read more about us!
Get in touch with us!
Visit us
Send us mail

Brinter aims to revolutionise the manufacturing of personalised drugs and bioprinted organ transplants with newly raised capital. The Turku-based company received million-dollar financing from private equity investor Innovestor.

The Turku-based bioprinting start-up received €1.2M in funding from the venture capital investor Innovestor. The company will use the capital to further expand its operations internationally in Europe and the US. Brinter boldly aims to put bioprinting within reach of every pharmaceutical company, hospital, university, and research center.

""
CEO Tomi Kalpio says that bioprinting means more personalized care.

Medical research facilities and universities often still rely on traditional methods of discovery in the research of new drugs, understanding diseases, and finding medical ways to help people.

“Bioprinting has the capability to rapidly unlock the opportunities behind long-running but unrealized science and research. This will improve the quality of life for patients, thanks to a more personalized care and bioprinted “spare parts” that can save lives, ” explains Brinter CEO Tomi Kalpio.

ProHealth Growth supporting growth

Brinter launched its first product in 2019, and is currently active in over 10 countries, including Germany and the UK. In 2020, Brinter was selected as one of the top eight 3D bioprinting companies in the world.

“Brinter is an exemplary success story of a promising start-up, and we are thrilled that the company is participating in the ProHealth Growth Programme, which provides a boost and support to Brinter’s successful business development”, tells Hanna Halme, Growth Advisor at Turku Science Park Ltd.

The Finnish national ProHealth Growth Programme is coordinated by Turku Science Park Ltd and offers participating companies webinars and one-on-one coaching, making use of programme’s strong network of individuals and companies with deep experience and wide-ranging Life Science competencies in fields like development, patenting, commercialization, legal, regulatory, quality and financing. More information about the programme here.

Last updated:
June 23, 2021

Turku Business Region

Turku Business Region gathers together the Turku region businesses, universities, organisations and municipalities. The 22,000 companies, six universities, and an extensive co-operation network of different players in the region speed up the generation of new products and services as well as growth of business operations and local well-being.

Click here to read more about us!
Get in touch with us!
Visit us
Send us mail